Sunovion Pharmaceuticals Overview

  • Year Founded
  • 1984

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,400

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.86B

Sunovion Pharmaceuticals General Information

Description

Provider of medical therapies designed to contribute to society through value creation based on research and development activities for the betterment of health care and fuller lives of people worldwide. The company's innovative therapies address serious psychiatric, neurological, and respiratory conditions, enabling people with serious medical conditions to lead fulfilling lives.

Contact Information

Formerly Known As
Sepracor
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 84 Waterford Drive
  • Marlborough, MA 01752
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sunovion Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Oct-2009 $2.86B 00.000 Completed Generating Revenue
2. IPO 20-Sep-1991 Completed Generating Revenue
1. Early Stage VC 01-Jan-1985 Completed Startup
To view Sunovion Pharmaceuticals’s complete valuation and funding history, request access »

Sunovion Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of medical therapies designed to contribute to society through value creation based on research and development
Clinics/Outpatient Services
Marlborough, MA
2,400 As of 2008
0.000 0000-00-00
000000&0

00000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
000000000000000
Rahway, NJ
00000 As of 0000
000.00
000000000 000.00

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
000000000000000
Basel, Switzerland
00000 As of 0000
0000
000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sunovion Pharmaceuticals Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Rahway, NJ 00000 000.00 000000000 000.00
Novartis Corporation Basel, Switzerland 00000 0000 000000000 0000
Mitsubishi Tanabe Pharma Corporate Backed or Acquired Doshomachi, Japan 0000 00000000000
Novo Nordisk Corporation Bagsvaerd, Denmark 00000 000000000
H. Lundbeck Corporation Copenhagen, Denmark 0000 00000000
You’re viewing 5 of 40 competitors. Get the full list »

Sunovion Pharmaceuticals Patents

Sunovion Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230170075-A1 Management of psychiatric or mental conditions using digital or augmented reality with personalized exposure progression Pending 01-Dec-2021 000000000 00
US-20230241024-A1 Methods of treating metabolic disorders Pending 23-Sep-2021 0000000000 0
AU-2022253074-A1 Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereof Pending 10-Apr-2021 0000000000
CA-3215043-A1 Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereof Pending 10-Apr-2021 0000000000
EP-4319738-A1 Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereof Pending 10-Apr-2021 C07D313/12
To view Sunovion Pharmaceuticals’s complete patent history, request access »

Sunovion Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sunovion Pharmaceuticals Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Domain Associates Venture Capital Minority 000 0000 000000 0
Glynn Capital Venture Capital Minority 000 0000 000000 0
Johnston Associates Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
SR One Capital Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Sunovion Pharmaceuticals Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cynapsus 21-Oct-2016 0000000000 00000 Pharmaceuticals 00000000
Sunovion Respiratory Development 05-Sep-2012 0000000000 00000 Drug Discovery 0000000 0
Sepracor Pharmaceuticals 04-Jun-2008 0000000000 0000 Pharmaceuticals 000000 00
ACADIA Pharmaceuticals 17-Jan-2006 0000 0000 Pharmaceuticals 0000000 0
ACADIA Pharmaceuticals 11-Jan-2005 PIPE 0000 Pharmaceuticals 0000000 0
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Sunovion Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
ACADIA Pharmaceuticals 17-Jan-2006 0000 0000 Completed
  • 00000000 000000000
ACADIA Pharmaceuticals 11-Jan-2005 PIPE 0000 Completed
To view Sunovion Pharmaceuticals’s complete exits history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »